Skip to main content

Table 2 Incidence density rates of malaria per 100 child-years of follow-up in the 1117 HIV-infected children included in the pWADA cohort, Abidjan, May-August 2012

From: Effect of cotrimoxazole prophylaxis on the incidence of malaria in HIV-infected children in 2012, in Abidjan, Côte d’Ivoire: a prospective cohort study

Characteristics

N

Number of child-years of follow-up

Incidence density rate with 95 % Confidence Interval for all cases of malaria: probable, confirmed including recurrences

Incidence density rate with 95 % Confidence Interval for confirmed malaria including recurrences

n (%)

Incidence density rate (per 100 child-years)

(95 % Confidence Interval)

n’ (%)

Incidence density rate (per 100 child-years)

(95 % Confidence Interval)

Incidence density rate of malaria

Cases without recurrences

1117

278

48 (94.1)

17.2

(12.4-22.1)

-

-

-

Recurrence cases

1117

278

3 (5.9)

1.1

(0.0-2.3)

-

-

-

Confirmed

1117

278

28 (55.0)

10.1

(6.3-13.8)

-

-

-

Probable

1117

278

23 (45.0)

8.3

(4.9-11.6)

-

-

-

Overall (confirmed and probable)

  

51 (100.0)

18.3

(13.3-23.4)

-

-

-

1117

278

Incidence density rate of malaria according to treatment

On ART – On Cotrimoxazole

667

166

7 (13.7)

4.2

(1.1-7.3)

4 (14.3)

2.4

(0.0-4.8)

Off ART – On Cotrimoxazole

83

21

3 (5.9)

14.5

(0.0-30.9)

2 (7.1)

9.7

(0.0-23.1)

On ART – Off Cotrimoxazole

323

80

36 (70.6)

44.7

(30.1-59.3)

19 (67.9)

23.6

(13.0-34.2)

Off ART – Off Cotrimoxazole

35

9

5 (9.8)

57.3

(7.1-107.6)

3 (10.7)

34.4

(0.0-73.3)

Immunodeficiency according to age a

Severe

69

17

5 (9.8)

29.4

(3.61-55.2)

3 (10.7)

17.5

(0.0-37.2)

Moderate

106

26

6 (11.8)

23.1

(4.6-41.5)

4 (14.3)

15.1

(0.3-30.0)

No/Missing

942

235

40 (78.4)

17.0

(11.7-22.3)

21 (75.0)

8.9

(5.1-12.8)

Age

<5 years

144

36

11 (21.6)

30.7

(12.5-48.8)

6 (21.4)

16.7

(3.3-30.1)

[5-10[years

443

110

20 (39.2)

18.1

(10.2-26.1)

12 (42.9)

10.9

(4.7-17.0)

≥10 years

530

132

20 (39.2)

15.1

(8.5-21.8)

10 (35.7)

7.6

(2.9-12.3)

Centres

University hospital of Cocody

182

45

1 (2.0)

2.2

(0.0-6.5)

1 (3.6)

2.2

(0.0-6.5)

University hospital of Yopougon

344

86

9 (17.6)

10.5

(3.6-17.4)

4 (14.3)

4.7

(0.1-9.2)

CePReF

322

80

23 (45.1)

28.7

(17.0-40.4)

11 (39.3)

13.7

(5.6-21.8)

CIRBA

212

53

7 (13.7)

13.3

(3.4-23.1)

2 (7.1)

3.8

(0.0-9.0)

MTCT-Plus

57

14

11 (21.6)

77.5

(31.7-123.2)

10 (35.7)

70.4

(26.8-114.1)

  1. aUsing te 2010 WHO definition. ART: antiretroviral therapy; n’() number and percentage of only confirmed malaria cases